Conduit Pharmaceuticals Files 8-K/A Amendment
Ticker: CDTTW · Form: 8-K/A · Filed: Apr 2, 2025 · CIK: 1896212
| Field | Detail |
|---|---|
| Company | Conduit Pharmaceuticals Inc. (CDTTW) |
| Form Type | 8-K/A |
| Filed Date | Apr 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, corporate-filing, other-events
TL;DR
Conduit Pharma (formerly Murphy Canyon) filed an 8-K/A amendment, check for updates on 'Other Events' from March 31st.
AI Summary
Conduit Pharmaceuticals Inc. filed an 8-K/A on April 2, 2025, to amend a previous filing. The amendment pertains to "Other Events" and the earliest event reported was on March 31, 2025. The company, formerly known as Murphy Canyon Acquisition Corp., is incorporated in Delaware and headquartered in Naples, Florida.
Why It Matters
This filing indicates an update or correction to a previous report by Conduit Pharmaceuticals, suggesting ongoing corporate activities or disclosures that investors should be aware of.
Risk Assessment
Risk Level: low — The filing is an amendment to a previous report and does not disclose new material events, indicating a low immediate risk.
Key Players & Entities
- Conduit Pharmaceuticals Inc. (company) — Registrant
- Murphy Canyon Acquisition Corp. (company) — Former company name
- March 31, 2025 (date) — Earliest event reported date
- April 2, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Naples, Florida (location) — Principal executive office location
FAQ
What specific "Other Events" are being amended in this 8-K/A filing?
The provided text does not specify the exact nature of the "Other Events" being amended, only that the filing is an amendment to a previous report concerning them.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 31, 2025.
What was Conduit Pharmaceuticals Inc. formerly known as?
Conduit Pharmaceuticals Inc. was formerly known as Murphy Canyon Acquisition Corp.
In which state is Conduit Pharmaceuticals Inc. incorporated?
Conduit Pharmaceuticals Inc. is incorporated in Delaware.
What is the principal executive address of Conduit Pharmaceuticals Inc.?
The principal executive address is 4851 Tamiami Trail North, Suite 200, Naples, FL 34103.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on April 2, 2025 regarding CONDUIT PHARMACEUTICALS INC. (CDTTW).